TIFFANI BETHEL: Open Payments
NPI 1598413825 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 75 payments from 16 companies in 2025. Trend: 2023 $599 · 2024 $1,828 · 2025 $1,350
Food & beverage: $1,350
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $268 |
| AstraZeneca Pharmaceuticals LP | 12 | $258 |
| Lilly USA, LLC | 11 | $178 |
| ABBVIE INC. | 11 | $153 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Phathom Pharmaceuticals, Inc. | 5 | $50 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Amgen Inc. | 3 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| PFIZER INC. | 2 | $44 |
Products named: AIRSUPRA, JARDIANCE, MOUNJARO, Ozempic, Wegovy, Rybelsus, UBRELVY, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
